BioMarin Pharmaceutical | BMRN - Equity Capital And Reserves

Biomarin Pharmaceutical reported $4.6B in Equity Capital and Reserves for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 400.41M 25.27M
Acorda Therapeutics ACOR:US USD 93.62M 17.86M
Agios Pharmaceuticals AGIO:US USD 1.1B 50.64M
Alnylam Pharmaceuticals ALNY:US USD -158223000 90.58M
Amgen AMGN:US USD 3.66B 8M
Bayer BAYN:GR EUR 38.77B 2.5B
Biogen BIIB:US USD 13.4B 622.4M
Biomarin Pharmaceutical BMRN:US USD 4.6B 34.64M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Gilead Sciences GILD:US USD 21.21B 128M
Insmed INSM:US USD 87.95M 117.91M
Intercept Pharmaceuticals ICPT:US USD 93.08M 14.6M
IONIS PHARMACEUT IONS:US USD 572.89M 21.47M
Moderna Inc MRNA:US USD 19.12B 1.13B
Neurocrine Biosciences NBIX:US USD 1.71B 163.2M
Ptc Therapeutics PTCT:US USD -347086000 120.18M
Puma Biotechnology PBYI:US USD 21.61M 547K
Regeneron Pharmaceuticals REGN:US USD 22.66B 1.23B
Roche Holding ROG:VX 27.99B 2.8B
Sangamo Biosciences SGMO:US USD 294.96M 14.2M
Sarepta Therapeutics SRPT:US USD 384.95M 45.89M
Seattle Genetics SGEN:US USD 2.8B 17.99M
Ultragenyx Pharmaceutical RARE:US USD 352.49M 116.34M
United Therapeutics UTHR:US USD 4.8B 234.5M
Vertex Pharmaceuticals VRTX:US USD 13.91B 883.1M
YTE INCY:US USD 4.37B 143.47M